Molecular Biosciences – SciLifeLab
SciLifeLab is a national center for molecular biosciences with focus on health and environmental research. This research facility combines frontline technical expertise with advanced knowledge of translational medicine and molecular bioscience.
Science for Life Laboratory – SciLifeLab – is a joint effort between four Swedish universities Karolinska Institutet (KI), KTH Royal Institute of Technology, Stockholm University and Uppsala University but serves as a national resource for all of Sweden. The infrastructure at SciLifeLab includes advanced technologies for high-throughput molecular biosciences. SciLifeLab is situated at two nodes: Stockholm and Uppsala and more than 200 research groups are associated with the center.
History of SciLifeLab
The SciLifeLab center was established in 2010, with support from the Swedish government. It's the results of strategic research funding in the field of molecular biosciences to a joint initiative from the Karolinska Institute, the KTH Royal Institute of Technology, Stockholm University and an initiative from Uppsala University. The government entrusted SciLifeLab with the assignment to be a national resource in 2013.
SciLifeLab at Karolinska Institutet
The Stockholm node of SciLifeLab is situated at Campus Solna. The close proximity to KI and the Karolinska University Hospital greatly facilitates collaborations with clinically oriented groups, and provide such groups easy access to the established infrastructure.
The funding’s for SciLifeLab under the strategic research areas was in 2013 released for research in each university. To deal with KI's activities in SciLifeLab the Board of Research at KI decided to create the KI SciLifeLab group.
The KI SciLifeLab group
The SciLifeLab group at KI is commissioned to manage available SFO funds and facilities within SciLifeLab, and to support KI Scientific Directors at SciLifeLab in their task to provide information to researchers at KI on how and to what one can use SciLifeLab. Placement of staff and allocation of funds should be made so that research that has the greatest potential for KI with regard to the development of new aspects on genomics, proteomics, imaging, bioinformatics, drug discovery and translational research is given priority. Members of the group are:
- Marie Wahren-Herlenius, Chairperson, Pro-Dean of Research
- Karin Dahlman-Wright,Vice-Chairperson, acting Vice-Chancellor
- Thomas Helleday
- Anna Wedell
- Mats Andersson, coordinator
Additional persons may be consulted on certain issues. Marie Wahren-Herlenius and Karin Dahlman-Wright are also members of the steering board of the SciLifeLab Stockholm node.
Today, SciLifeLab is a national center that develops, uses and provides access to advanced technologies for molecular biosciences with focus on health and environment. The national SciLifeLab is provided with SEK 150 million per year in state funds. A separate grant supports infrastructure in the field of drug discovery and development. Researchers from all of Sweden can use both the technology and the know-how that is present at SciLifeLab.
Contacts at Karolinska Institutet